What is the current valuation of the UK teleradiology market in 2024?

The overall market valuation was $240.32 Million in 2024. Read More

What is the projected market valuation for the UK teleradiology market by 2035?

The projected valuation for 2035 is $450.0 Million. Read More

What is the expected CAGR for the UK teleradiology market during the forecast period 2025 - 2035?

The expected CAGR during the forecast period 2025 - 2035 is 5.87%. Read More

Which segment had the highest valuation in the application category in 2024?

In 2024, Oncology Imaging had the highest valuation at $140.0 Million. Read More

What is the valuation range for Neuroimaging in the application segment?

The valuation range for Neuroimaging in the application segment is $60.0 Million to $120.0 Million. Read More

Which modality segment is projected to have the highest valuation in 2035?

The CT Scan modality is projected to have the highest valuation, ranging from $60.0 Million to $120.0 Million. Read More

What is the valuation range for hospitals in the end-use segment?

The valuation range for hospitals in the end-use segment is $80.08 Million to $150.0 Million. Read More

Which configuration type is expected to dominate the market by 2035?

The Web-Based configuration type is expected to dominate the market, with a valuation range of $90.32 Million to $150.0 Million. Read More

What is the valuation range for Diagnostic Imaging Centers in the end-use segment?

The valuation range for Diagnostic Imaging Centers in the end-use segment is $60.24 Million to $120.0 Million. Read More

UK Teleradiology Market

Q: Who are the key players in the UK teleradiology market?

Key players include Radiology Partners, vRad, Teleradiology Solutions, Mednax, TeleRadiology, Nighthawk Radiology, Global Diagnostics, and Onrad. Read More

ID: MRFR/HC/49963-HCR

200 Pages

Rahul Gotadki

Last Updated: February 06, 2026

UK Teleradiology Market Research Report By Application (Bone Imaging, Cardiac Imaging, Neuroimaging, Oncology Imaging, Chest Imaging), By Modality (X-Ray, CT Scan, MRI, Ultrasound, Nuclear Medicine), By End Use (Hospitals, Diagnostic Imaging Centers, Research Organizations, Home Healthcare, Emergency Care) and By Configuration (Cloud-Based, Web-Based, Standalone) - Growth & Industry Forecast 2025 To 2035

UK Teleradiology Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)5.87%

2024 Market Size$ 240.32 Million

2025 Market Size$ 254.42 Million

2035 Market Size$ 450 Million

Key Players

Radiology Partners

vRad

Teleradiology Solutions

Mednax

TeleRadiology

Nighthawk Radiology

Trends

Technological Advancements
Regulatory Support
Increased Demand for Remote Services

Opportunities

Rising Healthcare Costs
Shortage of Radiologists
Integration of AI Technologies

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Application (USD Million)
  1. 4.1.1 Bone Imaging
  2. 4.1.2 Cardiac Imaging
  3. 4.1.3 Neuroimaging
  4. 4.1.4 Oncology Imaging
  5. 4.1.5 Chest Imaging
2. 4.2 Pharmaceutical, BY Modality (USD Million)
  1. 4.2.1 X-Ray
  2. 4.2.2 CT Scan
  3. 4.2.3 MRI
  4. 4.2.4 Ultrasound
  5. 4.2.5 Nuclear Medicine
3. 4.3 Pharmaceutical, BY End Use (USD Million)
  1. 4.3.1 Hospitals
  2. 4.3.2 Diagnostic Imaging Centers
  3. 4.3.3 Research Organizations
  4. 4.3.4 Home Healthcare
  5. 4.3.5 Emergency Care
4. 4.4 Pharmaceutical, BY Configuration (USD Million)
  1. 4.4.1 Cloud-Based
  2. 4.4.2 Web-Based
  3. 4.4.3 Standalone
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Radiology Partners (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 vRad (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Teleradiology Solutions (IN)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Mednax (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 TeleRadiology (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Nighthawk Radiology (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Global Diagnostics (FI)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Onrad (AU)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 UK MARKET ANALYSIS BY APPLICATION
3. 6.3 UK MARKET ANALYSIS BY MODALITY
4. 6.4 UK MARKET ANALYSIS BY END USE
5. 6.5 UK MARKET ANALYSIS BY CONFIGURATION
6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
12. 6.12 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
13. 6.13 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 PHARMACEUTICAL, BY MODALITY, 2024 (% SHARE)
15. 6.15 PHARMACEUTICAL, BY MODALITY, 2024 TO 2035 (USD Million)
16. 6.16 PHARMACEUTICAL, BY END USE, 2024 (% SHARE)
17. 6.17 PHARMACEUTICAL, BY END USE, 2024 TO 2035 (USD Million)
18. 6.18 PHARMACEUTICAL, BY CONFIGURATION, 2024 (% SHARE)
19. 6.19 PHARMACEUTICAL, BY CONFIGURATION, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY MODALITY, 2025-2035 (USD Million)
  3. 7.2.3 BY END USE, 2025-2035 (USD Million)
  4. 7.2.4 BY CONFIGURATION, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

UK Pharmaceutical Market Segmentation

Pharmaceutical By Application (USD Million, 2025-2035)

Bone Imaging
Cardiac Imaging
Neuroimaging
Oncology Imaging
Chest Imaging

Pharmaceutical By Modality (USD Million, 2025-2035)

X-Ray
CT Scan
MRI
Ultrasound
Nuclear Medicine

Pharmaceutical By End Use (USD Million, 2025-2035)

Hospitals
Diagnostic Imaging Centers
Research Organizations
Home UK Teleradiology Market
Emergency Care

Pharmaceutical By Configuration (USD Million, 2025-2035)

Cloud-Based
Web-Based
Standalone

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”